Angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers should be considered as a first line of treatment for proteinuria associated with glomerulopathy, as such treatment leads to better renal survival than the use of immunosuppressive agents [37]. The gene discussed is ACE; the disease is lipoprotein glomerulopathy.